Enliven Therapeutics, Inc.
ELVN
37 insider filings · Latest: Oct 14, 2026
Common Stock Transactions
| Txn Date | Accepted | Insider | Type | Shares | Avg Price | Value | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|---|
| Jun 20, 2025 | Jun 20 8:02 PM | Lyssikatos Joseph P | Proposed Sale | 12,500 | $21.57 | $269.6K | — | View → |
| Jun 17, 2025 | Jun 17 8:15 PM | Kintz Samuel | Proposed Sale | 12,500 | $23.09 | $288.6K | — | View → |
| Jun 13, 2025 | Jun 13 8:08 PM | Hohl Benjamin | Proposed Sale | 3,000 | $19.99 | $60.0K | — | View → |
| Jun 9, 2025 | Jun 9 8:21 PM | Patel Anish | Proposed Sale | 6,667 | $20.74 | $138.3K | — | View → |
| Jun 3, 2025 | Jun 3 9:34 PM | Kintz Samuel | Proposed Sale | 7,500 | $19.14 | $143.6K | — | View → |
| Jun 3, 2025 | Jun 3 9:14 PM | Lyssikatos Joseph P | Proposed Sale | 7,500 | $19.14 | $143.6K | — | View → |
| May 27, 2025 | May 27 8:03 PM | Hohl Benjamin | Proposed Sale | 3,250 | $16.40 | $53.3K | — | View → |
| May 19, 2025 | May 19 8:22 PM | Kintz Samuel | Proposed Sale | 5,000 | $16.86 | $84.3K | — | View → |
| May 19, 2025 | May 19 8:21 PM | Lyssikatos Joseph P | Proposed Sale | 5,000 | $16.86 | $84.3K | — | View → |
| May 7, 2025 | May 7 8:11 PM | Patel Anish | Proposed Sale | 6,667 | $19.69 | $131.3K | — | View → |
| May 1, 2025 | May 1 8:03 PM | Lyssikatos Joseph P | Proposed Sale | 7,500 | $18.94 | $142.1K | — | View → |
| May 1, 2025 | May 1 8:02 PM | Kintz Samuel | Proposed Sale | 7,500 | $18.94 | $142.1K | — | View → |
| Apr 21, 2025 | Apr 21 8:28 PM | Lyssikatos Joseph P | Proposed Sale | 5,000 | $16.53 | $82.7K | — | View → |
| Apr 17, 2025 | Apr 17 8:19 PM | Kintz Samuel | Proposed Sale | 5,000 | $16.07 | $80.3K | — | View → |
| Apr 14, 2025 | Apr 14 8:54 PM | Patel Anish | Proposed Sale | 2,010 | $16.51 | $33.2K | — | View → |
| Apr 14, 2025 | Apr 14 8:48 PM | Patel Anish | Proposed Sale | 2,010 | $16.51 | $33.2K | — | View → |
| Apr 7, 2025 | Apr 7 8:09 PM | Patel Anish | Proposed Sale | 6,667 | $18.69 | $124.6K | — | View → |
| Mar 27, 2025 | Mar 27 8:01 PM | Hohl Benjamin | Proposed Sale | 4,250 | $20.58 | $87.5K | — | View → |
| Mar 19, 2025 | Mar 19 8:18 PM | Lyssikatos Joseph P | Proposed Sale | 12,500 | $20.28 | $253.5K | — | View → |
| Mar 18, 2025 | Mar 18 9:33 PM | Kintz Samuel | Proposed Sale | 21,531 | $21.04 | $453.0K | — | View → |
Stock Options & Derivatives
| Txn Date | Accepted | Insider | Type | Shares | Exercise Price | Shares Owned | Filing |
|---|---|---|---|---|---|---|---|
| Feb 12, 2026 | Feb 18 12:57 AM | Scott J. GarlandDirector | Grant/Award | 1,427 | $27.16 | 1,427(D) | View → |
| Feb 12, 2026 | Feb 18 12:56 AM | Mika K DerynckDirector | Grant/Award | 17,126 | $27.16 | 17,126(D) | View → |
| Feb 12, 2026 | Feb 18 12:56 AM | Jake BauerDirector | Grant/Award | 17,126 | $27.16 | 17,126(D) | View → |
| Feb 12, 2026 | Feb 18 12:55 AM | Rahul D. BallalDirector | Grant/Award | 17,126 | $27.16 | 17,126(D) | View → |
| Feb 12, 2026 | Feb 18 12:53 AM | Anish PatelCHIEF OPERATING OFFICER | Grant/Award | 120,000 | $27.16 | 120,000(D) | View → |
| Feb 12, 2026 | Feb 18 12:52 AM | Joseph P LyssikatosCHIEF SCIENTIFIC OFFICER | Grant/Award | 112,500 | $27.16 | 112,500(D) | View → |
| Feb 12, 2026 | Feb 18 12:49 AM | Benjamin HohlCHIEF FINANCIAL OFFICER | Grant/Award | 150,000 | $27.16 | 150,000(D) | View → |
| Feb 12, 2026 | Feb 18 12:47 AM | Helen Louise CollinsCHIEF MEDICAL OFFICER | Grant/Award | 150,000 | $27.16 | 150,000(D) | View → |
← Previous
Page 2 of 2